-
1
-
-
0028355939
-
Nasopharyngeal carcinoma: The Epstein-Barr virus association
-
Liebowtz D, Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semi Oncology, 1994, 21 (4): 376-381
-
(1994)
Semi Oncology
, vol.21
, Issue.4
, pp. 376-381
-
-
Liebowtz, D.1
-
2
-
-
0027449255
-
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
-
Kaye K M, Izumi K M, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Pro Natl Acad Sci USA 1993, 90 (19): 9150 -9154
-
(1993)
Pro Natl Acad Sci USA
, vol.90
, Issue.19
, pp. 9150-9154
-
-
Kaye, K.M.1
Izumi, K.M.2
Kieff, E.3
-
3
-
-
0033986419
-
LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4
-
Yang X, Sham J S, Cao L, et al. LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4. J Virol, 2000, 74 (2): 883-891
-
(2000)
J Virol
, vol.74
, Issue.2
, pp. 883-891
-
-
Yang, X.1
Sham, J.S.2
Cao, L.3
-
4
-
-
0032487999
-
Epstein-Barr virus latent membrane protein 1 signaling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions
-
Floettmann J E, Eliopoulos A G, Jones M, et al. Epstein-Barr virus latent membrane protein 1 signaling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions. Oncogene 1998, 17 (18): 2383-2392
-
(1998)
Oncogene
, vol.17
, Issue.18
, pp. 2383-2392
-
-
Floettmann, J.E.1
Eliopoulos, A.G.2
Jones, M.3
-
5
-
-
0031808429
-
Signal transduction from the Epstein-Barr virus LMP1 transforming protein
-
Farrell P J. Signal transduction from the Epstein-Barr virus LMP1 transforming protein. Trends Microbial 1998, 6 (10): 1731-1742
-
(1998)
Trends Microbial
, vol.6
, Issue.10
, pp. 1731-1742
-
-
Farrell, P.J.1
-
6
-
-
0032473910
-
Activation of the c-Jun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
-
Eliopoulos A G, Young L S. Activation of the c-Jun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene, 1998, 16 (13): 1731-1742
-
(1998)
Oncogene
, vol.16
, Issue.13
, pp. 1731-1742
-
-
Eliopoulos, A.G.1
Young, L.S.2
-
7
-
-
0026004501
-
Phosphorylation of c-jun mediated by MAP kinase
-
Pulverer B J, Kyriakis J M, Avruch J, et al. Phosphorylation of c-jun mediated by MAP kinase. Nature, 1991, 353 (6345): 670-674
-
(1991)
Nature
, vol.353
, Issue.6345
, pp. 670-674
-
-
Pulverer, B.J.1
Kyriakis, J.M.2
Avruch, J.3
-
8
-
-
0030826412
-
A cytoplasmic inhibitor of the JNK signal transduction pathway
-
Dickens M, Roger J S, Cavanagh J, et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science, 1997, 277 (5326): 693-696
-
(1997)
Science
, vol.277
, Issue.5326
, pp. 693-696
-
-
Dickens, M.1
Roger, J.S.2
Cavanagh, J.3
-
9
-
-
0141719170
-
Epstein-Barr virus LMP-1 activated AP-1 mediated by JNK in nasopharyngeal cell line
-
Luo F J, Hu Z, Cao Y, et al. Epstein-Barr virus LMP-1 activated AP-1 mediated by JNK in nasopharyngeal cell line. Chin J Biochem Mol Biol, 2001, 17 (8): 381-385
-
(2001)
Chin J Biochem Mol Biol
, vol.17
, Issue.8
, pp. 381-385
-
-
Luo, F.J.1
Hu, Z.2
Cao, Y.3
-
10
-
-
0036676014
-
LMP1 activates the JNK pathway through its CTAR1 via a mechanism involving TRADD and TRAF in nasopharyngeal carcinoma cells
-
Hu Z, Zeng L, Cao Y, et al. LMP1 activates the JNK pathway through its CTAR1 via a mechanism involving TRADD and TRAF in nasopharyngeal carcinoma cells. Prog Biochem Biophys, 2002, 29 (4): 562-566
-
(2002)
Prog Biochem Biophys
, vol.29
, Issue.4
, pp. 562-566
-
-
Hu, Z.1
Zeng, L.2
Cao, Y.3
-
11
-
-
0030800330
-
Inhibitors of both nuclear factor-kappa B and activator protein-1 activation block the neoplastic transformation response
-
Li J J, Westergaard C, Ghosh P, et al. Inhibitors of both nuclear factor-kappa B and activator protein-1 activation block the neoplastic transformation response. Cancer Res, 1997, 57 (16): 3569-3576
-
(1997)
Cancer Res
, vol.57
, Issue.16
, pp. 3569-3576
-
-
Li, J.J.1
Westergaard, C.2
Ghosh, P.3
-
12
-
-
0031857536
-
UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: Requirement of an AP1 enhancer element
-
Miralles F, Parra M, Caelles C, et al. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element. Mol Cell Biol, 1998, 18 (8): 4537-4547
-
(1998)
Mol Cell Biol
, vol.18
, Issue.8
, pp. 4537-4547
-
-
Miralles, F.1
Parra, M.2
Caelles, C.3
-
13
-
-
0037792246
-
The establishment and biological characteristics of four-nasopharyngeal carcinoma cell lines
-
Zhu H C, Yao K T, Li G Y, et al. The establishment and biological characteristics of four-nasopharyngeal carcinoma cell lines. Bull Hunan Med Univ, 1992, 17 (2): 103-107
-
(1992)
Bull Hunan Med Univ
, vol.17
, Issue.2
, pp. 103-107
-
-
Zhu, H.C.1
Yao, K.T.2
Li, G.Y.3
-
14
-
-
20444381750
-
Doxycline dependent expression of Epstein-Barr virus latent membrane protein 1 with Tet regulating system in nasopharyngeal carcinoma cell line
-
Liao W, Yi H, Cao Y, et al. Doxycline dependent expression of Epstein-Barr virus latent membrane protein 1 with Tet regulating system in nasopharyngeal carcinoma cell line. Acta Biochem Biophys Sin, 1999, 31 (3): 309-312
-
(1999)
Acta Biochem Biophys Sin
, vol.31
, Issue.3
, pp. 309-312
-
-
Liao, W.1
Yi, H.2
Cao, Y.3
-
15
-
-
0032508714
-
A mammalian scaffold complex that selectively mediates MAP kinase activation
-
Whitmarsh A J, Cavanagh J, Tournier C, et al. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science, 1998, 281 (5383): 1671-1674
-
(1998)
Science
, vol.281
, Issue.5383
, pp. 1671-1674
-
-
Whitmarsh, A.J.1
Cavanagh, J.2
Tournier, C.3
-
16
-
-
0034644522
-
Signal transduction by the JNK group of MAP Kinase
-
Davis R J. Signal transduction by the JNK group of MAP Kinase. Cell, 2000, 103 (2): 239-252
-
(2000)
Cell
, vol.103
, Issue.2
, pp. 239-252
-
-
Davis, R.J.1
-
17
-
-
0032980723
-
The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells
-
Bost F, McKay R, Bost M, et al. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol Cell Biol, 1999, 19 (3): 1938-1949
-
(1999)
Mol Cell Biol
, vol.19
, Issue.3
, pp. 1938-1949
-
-
Bost, F.1
McKay, R.2
Bost, M.3
|